K-numberK243446
Device name3DXR
ApplicantGE Medical Systems SCS
Product codeOWB
Device classClass II
Decision dateFeb 25, 2025
DecisionSubstantially Equivalent
Regulation892.1650
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

3DXR is a post-processing software application that runs on the Advantage Workstation platform and performs three-dimensional reconstruction of cone-beam CT (CBCT) images acquired from interventional X-ray systems. The reconstructed 3D volumes are used by physicians for diagnosis, surgical planning, interventional procedures, and treatment follow-up of vessels, bones, soft tissues, and other internal body structures.

Technological characteristics

The proposed 3DXR includes a new CleaRecon DL option powered by deep-learning convolutional neural networks to remove streak artifacts caused by pulsatile blood flow, an enhanced 3DStent feature that compensates for both respiratory and cardiac motion (vs. respiratory only in the predicate), and improved Imaging Purposes functionality. All other features—Motion Freeze, Metal Artifact Reduction, Active Tracker Detection, Iodine Streaks Reduction, Scatter Reduction, Extended Range, and CT Format—remain identical to the predicate device.

Test standards cited

NEMA PS 3.1–3.20 Digital Imaging and Communications in Medicine (DICOM) standard; 21 CFR 820 Quality System Regulations; ISO 13485.

Substantial equivalence argument

The device maintains identical indications for use and intended use as the predicate. Design control testing identified no new hazards or unexpected results. The CleaRecon DL deep-learning algorithm was validated through engineering bench testing (showing statistically significant reduction in Mean Absolute Error and increase in Structural Similarity Index on test datasets independent of training data) and retrospective clinical evaluation across 110 patient exams from 13 sites, where 98% of physicians rated CleaRecon DL-reconstructed images as clearer than conventional reconstructions with no artificially created or hidden anatomical structures. The adult-only population limitation for CleaRecon DL is a narrowing of use, not a new safety concern.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →